Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
David Standaert
Massachusetts General Hospital, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Teva Neuroscience, Inc.
Reimbursed or sponsored travel
The outcome of the research is of significant business interest to the entity and therefore the financial interest could likely change based on the research results.
Molecular etiology of early onset dystonia
A multidisciplinary team of investigators will focus on elucidating common cellular and neurologic pathways underlying early onset dystonia to reveal potential therapies.
Filed on September 21, 2015.
Tell us what you know about David Standaert's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “David Standaert”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| David Standaert | Massachusetts General Hospital | Conflict of Interest | Serina Therapeutics | $10,000 - $19,999 |
| David Standaert | Massachusetts General Hospital | Conflict of Interest | AstraZeneca Pharmaceuticals | $10,000 - $19,999 |
| David Standaert | Massachusetts General Hospital | Conflict of Interest | Teva Neuroscience, Inc. | $5,000 - $9,999 |
| David Standaert | Massachusetts General Hospital | Conflict of Interest | AbbVie, Inc. | $20,000 - $39,999 |
| David Standaert | Massachusetts General Hospital | Conflict of Interest | AbbVie, Inc. | $0 - $4,999 |
| David Standaert | University of Alabama at Birmingham | Conflict of Interest | SERINA THERAPEUTICS | $5,000 - $9,999 |
| David Standaert | University of Alabama at Birmingham | Conflict of Interest | TEVA THERAPEUTICS, INC. | $10,000 - $19,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.